Founded in 2014, HUINNO is a venture-backed company with offices in Boston, New York, and Seoul. They have developed breakthrough technologies in wearable devices and AI-based analytics cloud to change the way clinicians and patients manage chronic cardiac diseases. Their clinically-tested platform continuously measures vital health data in real-time with clinical-grade accuracy, providing superior real-time cardiac biometrics including ECG, Blood Pressure, Heart Rate, and SpO2. HUINNO's remote patient monitoring solution improves chronic cardiac disease prevention and lowers readmission rates compared to the existing standard of care. Their app and cloud-based ecosystem offer consumers access to longitudinal trend analysis of blood pressure, medication compliance, and exercise habits, as well as coaching and medication titration from HUINNO's clinical experts.